ABSTRACT -Background -Hepatitis B and C are diseases with high morbimortality and constitute a global public health problem. In Brazil, the prevalence is not homogeneous, oscillating among different regions, but it is estimated that currently about 1% of the population present chronic disease related to the B virus and that there are 1.5 million infected with the C virus. Despite the development of hepatitis B vaccine, improvement in diagnostic methods and therapeutic advances in the field of viral hepatitis, there is still a large number of people who continues to be infected by these viruses, especially in populations at risk and also due to several factors, including vaccination and migration policies. Vertical and perinatal transmissions are of great importance in the epidemiology of viral hepatitis and the blood tests performed during prenatal care constitute a great opportunity for screening and identifying these viruses. ) and seven positive anti-HCV patients (1.3%) were observed. There was no significant association between age and positivity for HBsAg, anti-HBs and anti-HCV (P =0.205, 0.872 and 0.676, respectively). There was a direct relationship between the anti-HBs positivity and the last four years of the study (P<0.0001). Conclusion -A high prevalence of HBsAg was observed, higher than the expected for the evaluated region; there was a prevalence of anti-HCV, consistent with the current Brazilian reality; and a likely low rate of hepatitis B immunization, with a relatively high rate of susceptibility to this infection and no case of co-infection between B and C viruses and HIV. It is emphasized not only the need to trace hepatitis B and C, without exceptions, during prenatal care, since even though the current advances in therapy may not cure, at least they may allow a better quality of life for patients with chronic disease and the mandatory completion of immunoprophylaxis in all newborns. Special attention should be given to those patients susceptible to HBV, with prompt diagnosis and referral for specific vaccination.
INTRODUCTION
Hepatitis B virus (HBV) and C virus (HCV) are diseases with high morbimortality. HBV infection continues to be a global public health problem, with changes in its epidemiology due to several factors, including vaccination and migration policies. Approximately two billion people have been infected by HBV, and 20 million are infected annually, existing about 240 million chronic carriers of this virus. The variable geographic prevalence is highest in Africa and Asia (1, 2) . In Brazil, despite the introduction of the vaccine in the Western Amazon in 1989 and progressive efforts of immunization and prevention by the Sistema Único de Saúde (SUS), hepatitis B transmission is still a reality. The country was previously considered Hepatitis B and C in pregnant women attended by a prenatal program in an universitary hospital in Rio de Janeiro, Brazil: retrospective study of seroprevalence screening to be of intermediate endemicity, with great heterogeneity among regions and areas of high prevalence, especially in the Amazon Basin. Between 2004 and 2009, a populational study reported lower prevalence in all regions of Brazil. The most recent results indicated a reduced prevalence of hepatitis B throughout the country, classifying Brazil as being of low endemicity. Most studies showed a prevalence of HBV inferior to 1% (3) (4) (5) (6) (7) . Although there is a HCV pandemic, its distribution is variable in different regions of the world. The World Health Organization (WHO) estimates that 3% of the world's population is chronically infected with this virus and that 3-4 million people are infected each year, with 130-170 million chronic carriers at high risk of developing chronic liver disease, cirrhosis and hepatocellular carcinoma. Approximately 350,000 deaths occur each year due to HCV-related liver disease. Although HCV infection incidence rate is apparently slowing in the developed world, deaths from liver diseases secondary to HCV will continue to increase over the next 20 years (8) (9) (10) . Brazil, with about 1.5 million chronically infected people, is considered by the WHO as a country with intermediate density.
The country has a vast territory with unequal population density and HCV incidence rates are variable, with the majority of cases concentrated in the most populated areas. Population-based and blood donor studies revealed lower prevalences than estimated, placing Brazil as low endemicity (4, 11) . From 1999 to 2016, 319,751 cases of hepatitis C were detected in the country with anti-HCV or HCV-RNA reagents and 155,032 cases considering those that displayed both markers positive. Most of these cases were observed in the Southeast (24.5%) and South (5.5%) regions. This detection rate with anti-HCV and HCV-RNA reagents displayed a growth trend between 2003 and 2016 in all Brazilian regions. From 2015 on, cases were confirmed using only HCV-RNA, offering a more precise definition of an infection case, and consequently increasing the detection rate in all regions of the country. The number of deaths related to this etiology has increased over the years in all regions of Brazil (4) . The prevalence of HBV and HCV in a population is related to risk factors associated with the transmission, such as blood transfusion and blood products, dental and surgical procedures, use of tattoos, accidents with biological material, use of injectable substances, besides the sexual and vertical routes (12, 13) . Maternal-fetal transmission is of great importance in the epidemiology of viral hepatitis. In children of HBV infected mothers, vertical transmission carries a risk of progression to chronicity in 70%-90% of the cases (14, 15) . The present study had as objectives: to determine the seroprevalence of hepatitis B and C in the prenatal patients of the Hospital Hospital Universitário Antônio Pedro, Niterói, Rio de Janeiro; to compare the data found with the regional data and those described in the specific literature and to provide demographic, clinical and epidemiological data to the literature that may be used for the formulation of policies in the area.
There are few studies in national and international literature addressing the prevalence of hepatitis in pregnant women. As this is a still worldwide worrying and the early detection in prenatal care can avoid a series of deleterious outcomes for the pregnant woman and its child, the concern of deepening the study in this area arose with a more accurate evaluation of the epidemiological profile of pregnant women from the region. Thus, prenatal exams provide a great opportunity for screening and identifying these viruses in this population that could serve as a natural reservoir for future generations.
METHODS
A cross-sectional, descriptive study of the quantitative type with retrospective data collection was carried out, with medical records of pregnant women who attended the Prenatal Service of the Hospital Universitário Antônio Pedro (HUAP) from March 2006 to December 2013. The hospital, located in Niterói, attends patients from the Metropolitan Region II of Rio de Janeiro, which also includes the municipalities of São Gonçalo, Maricá, Itaboraí, Tanguá, Silva Jardim and Rio Bonito. Appointments were made with the MV2000 -Hospital information system, used at HUAP since 2006. The study period ran from March 2006 to December 2013. The data were collected from prenatal records, via previously validated protocols.
All the records of pregnant women registered in the system were eligible for inclusion in the study, reaching a total of 13,771 attendances (first and subsequent prenatal appointments). Finally, 635 randomly generated records were selected by querying the Oracle database of the MV2000 system. General variables such as age, municipality of origin, year of follow-up, gestational age, prenatal risk, number of visits performed during prenatal care, previous obstetric and clinical history, intercurrences during pregnancy or delivery, beginning of sexual life, number of partners, gestational outcome, and specific variables such as history of vaccination for hepatitis B and the results of viral markers for hepatitis B and C. As for age, patients were categorized into three groups: under 20, 20 to 35 and over 35 years of age. For the purpose of this study, the frequency of prenatal appointments was categorized into three groups and considered "insufficient" (less than six visits), "adequate" (six to ten visits) and "optimal" (more than ten visits). Regarding the number of pregnancies, the women were divided into three groups: primigravidae (single gestation), multiparous (between two and three gestations) and large multiparous (above three gestations). The gestational outcomes considered were vaginal delivery, cesarean section, abortion and ignored (delivered elsewhere than in HUAP and not reported in the medical record). In "reported vaccination" there were three possible answers: yes, no, unknown (not mentioned in the medical records). The viral markers were defined as positive, negative and absent (not requested or the result was not documented in the medical record). The database was built in the Microsoft Office Access program and was later exported to Microsoft Office Excel. For the processing and analysis of the data, it was used the SPSS (Statistical Package for Social Science, IBM) version 22.0, for Windows. For the age, the average, standard deviation (SD), median and confidence interval (CI) were calculated. This variable was also explored by verifying the distribution of normality, to test the established hypotheses. From the Kolmogorov-Smirnov test it was defined that the Mann-Whitney test would be used to verify the existence of significant differences between the ranked averages of the ages in the groups of viral markers, positive and negative. The Kruskal-Wallis tests with Tukey's post-Hoc test were used to verify if there was a difference between the years of research (eight categories) and the age of the pregnant women. Categorical variables were analyzed via relative and absolute frequency tables. To verify the possible association between these variables, the Chi-square test was conducted, employing the Fisher's exact test. In addition to the verification of the P-value, in the binary tabulations, the odds ratio was established observing the absence of the number 1 in the CI 95%. All tests presented P<0.05. The research complied with Resolution 196/1996, which deals with research with human beings and was approved by the Research Ethics Committee of the Universidade Federal Fluminense (UFF), under opinion 977.674/2015 and CAAE 41681014.6.0000.5243.
RESULTS
The age of pregnant women varied from 12 to 46 years, with median and average of 27 years (26.4-27.5), with standard deviation ±6.92 (SD). In relation to the age groups, there were 98 women under the age of 20, 465 women between 20 and 35 years and 72 of them over the age of 35 years. There was no significant difference between the age of the patients during the years of research (P=0.384). The number of appointments ranged from 1 to 16, with an average of 7. An adequate number of appointments predominated in women over 35 years of age. The number of pregnancies ranged from 1 to 8 (average of 2.3). From 469 completed deliveries, 164 (34.9%) were vaginally and 305 (65.1%) were delivered via cesarean section. The main indications of cesarean section were: iterativity, cephalopelvic disproportion and acute fetal distress. The clinical-demographic characteristics of the study population are summarized in TABLE 1.
As for the viral markers, 12 (12/631) returned positive HBsAg (1.9%), 189 (189/526) positive anti-HBs (35.9%) and seven (7/560) positive HCV (1.3%). The response to HBV vaccination was positive in 23 (3.6%) patients and negative in 35 (5.5%). This information was not included in 577 (90.9%) medical records. The results of the hepatitis B and C markers and the vaccination history for HBV and markers per year of this survey can be seen in TABLE 2 and FIGURE 1 respectively. The positive HBsAg cases predominated in the 20-35-year-old age group (90%), with an average of 26 years, but according to the Mann-Whitney test, the difference between the age groups was not significant (P=0.205). There was a prevalence of positive HBsAg cases in the years 2006, 2007 and 2012 (over 80%) -FIGURE 1. According to the number of pregnancies, 41% were primigravidae and 58% were multiparous. Regarding the history of previous vaccination, six women denied having been vaccinated for hepatitis B and in six cases this fact was unknown. Other possible risk factors for HBV infection were identified in only three cases: habitual use of injectable medication due to chronic disease, drug-using sexual partner and mother with hepatitis B, the latter suggesting vertical HBV transmission. The diagnosis in 67% of the cases was carried out in prenatal care. It was possible to identify, according to reports in the medical records, four cases of inactive patients with HBsAg, one of acute hepatitis already in convalescence and two of patients with chronic hepatitis, one positive HBeAg and the other negative HBeAg. There was no case of co-infection with HCV.
Anti FIGURE 3 ). There was no significant difference between the average age of patients that returned positive and negative for anti-HBs (P=0.907).
Seven patients with HCV-positive serologies (1.3%) were identified, and five cases (71.4%) were diagnosed in the prenatal period. The age ranged from 18 to 46 years, with a mean of 28.8 years and blood transfusion was considered a risk factor for three patients, and it was not possible to identify the presence of risk factors for the remaining cases.
DISCUSSION
In the pregnant women group, average maternal age was 27 years, outlining the profile of pregnant women as a young population that, from a reproductive point of view, is considered optimal because it represents a lower perinatal risk (16) . There was a significant percentage of pregnant adolescents (younger than 20 years) who reached 15.4% of the total number of women evaluated. Despite falling rates, the incidence of pregnant adolescents in Brazil is considered high, and it is estimated that 20%-25% of all pregnant women in Brazil are adolescents (17, 18) . Manfré and collaborators (19) observed in a study on Latin America that among 25% of the poorest population, one in three births originates from an adolescent mother, increasing this proportion even more in rural areas. Pregnancy in this population group has been considered a public health problem in some countries, since it can lead to obstetric complications, with repercussions for the mother and the newborn, as well as psychosocial and economic problems (20) . Late pregnancies (older than 35 years) have been increasing in Brazil and in the world, demonstrating a trend that is taking place mainly in industrialized countries and is considered a pre-existing gestational risk factor by the Ministry of Health, requiring special attention in prenatal care. Late pregnancy was observed in 11.3% of the women studied, lower than the 13.0% found in the literature (21, 22) . The fertility rate, which is an estimate of the number of children a woman has throughout her life, has been declining in Brazil since the end of the 1960s, from 2.4 to 1.8 in the period from 2000 to 2015, but remained higher in the rural area, with about 2.7 children per woman. The Southeast Region has the lowest national average, equal to 1.75. Factors such as the expansion of urbanization, sexual education and family planning, with more widespread use of contraceptive methods, greater participation of women in the labor market, and higher costs of raising and educating children appear to be contributing to this decline. In the present study there was a predominance of multiparous, with the average number of pregnancies found in the evaluated period equal to 2.3, higher than that found for the Southeast region according to the demographic census of 2010 (23) . The definition of an ideal number of appointments is important for the elaboration of health care protocols and resource planning. The Prenatal and Birth Humanization Program makes it possible to classify as appropriate every prenatal follow-up initiated up to the fourth month of gestation with six or more appointments, one in the first trimester, two in the second and three in the third trimester (24) . The last National Demography and Health Survey, conducted in 2006, revealed a 80.9% coverage for prenatal care with six or more visits (25) . The average score was equal to seven visits, with 66.7% of the cases with more than six queries defined in this study as an optimal number, although this proportion is lower than the one observed in Brazil (26) . Inferior proportional adherence to the appointments was observed in the age of less than 20 years, and this fact was also demonstrated in studies conducted in other Brazilian regions, which showed an association between pregnancy in adolescence and a smaller number of prenatal appointments (27) . The highest percentage of appointments with a number greater than six (75.0%) were found in the group above 35 years of age, probably because the pregnancies of elderly women have been considered as high risk, mainly due to increased incidence of hypertensive syndromes, premature rupture of membranes, presence of diabetes, and a greater chance of complications for the newborn (28) . There was a predominance of cesarean delivery in this study, 65% of cases, even though WHO recommends that this percentage should not exceed 15%. The prevalence of cesarean section over vaginal delivery occurred in all age groups evaluated. The high rate of cesarean deliveries in the Brazilian context stands out as alarming, especially when compared to data of countries with low rates (14.0%-18.0%) such as the Netherlands, Czech Republic, Slovakia, Norway and Sweden and even those with rates considered high (30.0%-33.0%) such as the United States, Portugal, Australia, Korea, Italy and Mexico (29) . It is important to note that the HUAP prenatal outpatient clinic is a reference for pregnancy with any type of risk, obstetric or not, and that, of the cases studied here, more than 71% were pregnant women considered to be at risk.
The prenatal blood tests represent a valuable opportunity for the diagnosis of hepatitis B and its manifestations, contributing to the decrease of the prevalence of this disease and its complications. Machado Filho et al. reported a variation of the prevalence of HBsAg from 0.3% to 1.7% in Brazil, except in some regions of the Amazon. Similar data are found in other countries, except in regions of Africa and Asia where prevalence can reach up to 15%. (30) In an epidemiological study conducted in Brazil, the overall prevalence of the HBsAg marker for the Brazilian capitals was 0.37% (6) . In pregnant women, the prevalence of hepatitis B varies according to the endemicity of the infection in the geographic region and population studied. However, there are few studies on the screening of the disease in the gestational period in Brazil, especially in the state of Rio de Janeiro. Souza et al. reported a prevalence of chronic HBV among Brazilian pregnant women ranging from 0.5% to 8.7%, depending on the region studied (5) . Twelve women positive for HBsAg were detected in this study, with an estimated prevalence of 1.9%. This prevalence varied according to the years of research when the cases were observed (31) , in this study there was no growth in its prevalence with the increase in age.
In the Rio de Janeiro state, the detection rate of Hepatitis B showed significant growth until 2009, displaying a decrease in 2010, with a new increase in 2011, exhibiting a new downward trend as of 2012 (32) . The prevalence of HBV presented here has important implications for both health managers and for the effectors of the health service, especially physicians involved in its care, and emphasize the importance of carrying out similar surveys in this region.
Studies on the vertical transmission of hepatitis B are rare in Brazil, since the HBsAg research began to compose the prenatal routine only after 2005 (33) . The Ministry of Health, through the Epidemiological Bulletin of Viral Hepatitis, presented the vertical transmission of hepatitis B as the third most frequent category of infection, only below the sexual and domiciliary contact, and the reported transmission rate was 5.9% (4) . In the presence of chronic HBV, a greater incidence of maternal and fetal complications has been reported if compared to the rest of the population, but these data are still conflicting (34) . In five cases of positive HBsAg patients, complications related specifically to gestation (retrocorionic hematoma, oligohydramnios and premature amniorrexis) were found. In relation to newborns, prematurity was reported in three cases. There were insufficient data in the records to assess possible cases of HBV via vertical transmission.
In the absence of maternal antiviral treatment or immunoprophylaxis when indicated, the chronification percentage of HBV-infected newborn by vertical transmission may reach 90%, with an increased risk of developing disease-related complications at an early stage in life (7, 15, 35) . In the 1990s, WHO recommended that hepatitis B vaccination must be incorporated into national vaccination programs. Also in this same decade the vaccine was offered by the SUS. Since 1998, the National Immunization Program of the Ministry of Health has begun to recommend universal vaccination of children from birth (36) . Anti-HBs were positive in 189 pregnant women. This positivity was more observed as of 2010, especially in the 20-35 age group, and 2013 was the only year in which the number of cases with positive anti-HBs was higher than those with negative anti-HBs. This direct relationship between the anti-HBs positivity and the last years of the research was statistically significant (P<0.0001) and probably related to the improvement of vaccination coverage in the country in recent years.
The low relative immunization rate observed in this population of pregnant women requires better investigation and should be clarified if it was due to an inadequate medical recommendation for vaccination or the noncompliance of the patients to this recommendation, or if it was the result of a possible defective immune response to the vaccination.
Regarding HCV in the evaluated group, seven patients with positive anti-HCV were identified, with a global prevalence estimated at 1.3%. The prevalence found in this research was higher than those reported by Nunes and collaborators (0.1%) (37) , Rodrigues Neto et al. (0.3%) (38) and Carvalho et al. (0.9%) (39) , but similar to that found in a 2010 study led by researchers from University of Pernambuco (40) , in which the prevalence of all Brazilian capitals was 1.38%. Licata and collaborators (41) reported a prevalence among pregnant women between 1% and 2% in the United States and Europe but could reach up to 8% in developing countries.
Studies in Brazil did not detect differences between the prevalence of hepatitis C in pregnant women and in the general population (42) . However, these prevalences may be underestimated since the practice of screening was adopted only in pregnant women belonging to groups that are more likely to be infected and may ignore a large number of HCV cases (43) . According to WHO, Brazil is considered a country of intermediate endemicity. However, population-based and blood donor studies revealed lower prevalences than those estimated, placing Brazil as low endemicity (4, 5, 7) . This divergence is probably explained by the use of seroprevalence studies in specific groups that do not necessarily represent the general population (39) . The age of positive anti-HCV patients in the present study ranged from 18 to 46 years, with an average of 28.8 years (SD ±9.04). Pereira and collaborators (44) reported an increase in exposure to HCV with age. Oliveira et al. (45) also observed an association between positive anti-HCV and age over 40 years. In their study, Wang and colleagues (46) suggested that hepatitis C affects people of all ages, but there is a peak incidence between 20 and 39 years of age and a higher prevalence rate in the 30-49 years range. In the casuistry of the present study, six patients were older than 25 years and all were born before 1989 and no statistically significant difference was observed in age and anti-HCV positivity (P=0.676).
As in the case of hepatitis B, hepatitis C transmission is relatively stable in Brazil in terms of number of new cases diagnosed each year during the period between 2004 and 2014, except for 2013. The majority of cases reported in Brazil are concentrated in the Southeast and South regions (4) . In any case, the HCV in pregnant women addresses the need for a routine investigation of this infectious disease during prenatal care. Vertical HCV transmission is less frequent than that of HBV and might encompass between 3% and 10% of the cases (47, 48) . The patients in this study had no complications during pregnancy or childbirth attributable to HCV. Intercurrences with newborns were also not reported.
FINAL CONSIDERATIONS
This is the first study that evaluates the seroprevalence of hepatitis B and C in pregnant women attended in the city of Niterói (RJ) and, although it is limited to the population of pregnant women attended at HUAP and does not represent the population as a whole, it can serve as a base for the adoption of public policies in the municipal and state scenario, contributing to changes. A high prevalence of HBV, above that expected for the region, was observed; a prevalence for HCV consistent with the current Brazilian reality; a low rate of hepatitis B immunization, with a high index of susceptibility to this infection; and no case of co-infection.
The availability of the vaccine against HBV and the appearance of new drugs that can control the chronic disease, besides the knowledge of measures that prevent transmission, including vertical transmission, has a real chance of controlling this disease.
To prevent the prevalence of HCV from continuing to increase worldwide, a global effort is needed to strengthen care for primary prevention, including the development of vaccines and new approaches to secondary and tertiary prevention, reducing cases of chronic liver disease and improving the survival of the carriers.
There is a need to encourage research on the prevalence and incidence of these diseases in pregnant women, in order to plan strategies for prevention, prophylaxis and treatment of these infections, avoiding the damaging effects on the mother and her child and consequently raising costs to the health system.
It is important to carry out more research in pregnant women in this area as well as the prenatal screening of hepatitis B and C, with no exceptions, since even though the current advances in therapy may not cure, at least they may allow a better quality of life for patients with chronic disease. It is also emphasized the need for mandatory immunoprophylaxis for all newborns and special attention should be given to those patients susceptible to HBV, with prompt diagnosis and referral for specific vaccination.
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